[Hendi Pharmaceutical: expected net profit for the first half of the year will increase 84% over the same period last year]-- Hendi Pharmaceutical announced that it is expected to make a net profit of 100 million yuan to 130 million yuan in the first half, an increase of 83.82% and 138.98% over the same period last year. The market demand for ibuprofen raw material drugs and dextral ibuprofen raw material drug products has increased, and the market demand for ibuprofen-related preparation products has increased.